地奧司明
品名: 地奧司明
CAS NO: 520-27-4
純度:90%
顏色:淺黃色粉末
檢測方式:HPLC
分子式:C28H32O15
分子量;608.54
產品名稱 地奧明，地奧司明
英文名稱： Diosmin
英文別名：3',5,7-trihydroxy-4'-methoxyflavone 3,5,7-Trihydroxy-4-methoxyflavone-7- rutinoside ；7-rutinoside;
: 醫藥原料和中間體
產品含量: 92%
化學式: C28H32O15
CAS編號: 520-27-4
包裝規格: 25公斤/桶
產品說明: 本品為淺黃色吸濕性粉末。
水份<6．0%
殘渣<0．2%
重金屬<20ppm
溶解性：幾乎不溶于水，溶于二甲基亞砜，幾乎不溶于乙醇。溶于稀的碱性溶液。
產品詳詢：13657416805
參考文獻：
- 1.W. Henning, Z. Lebensm. Unters. Forsch. 173 (1981) 180–187.
- 2.K. Kanes, B. Tisserat, M. Berhow, C. Vandercook, Phytochemistry 32 (1993), 967–974.
- 3.S. Mizrahi, Z. Berk, J. Sci. Food Agric. 21 (1970) 250–253.
- 4.B. Berkarda, H. Koyuncu, G. Soybir, F. Baykut, Res. Exp. Med. (Berl). 198 (1998) 93–99.
- 5.E.M. Galati, A. Trovato, S. Kirjavainen, A. Forestieri, A. Trovato, M.M. Tripodo, Farmaco 40 (1994), 709–712.
- 6.H. Koyuncu, X. Berkarda, F. Baykut, G. Soybir, C. Alatli, H. Gul, M. Altun, Anticancer Res. 19 (1999) 3237–3242.
- 7.M.T. Monforte, A. Trovato, S. Kirjavainen, A.M. Forestieri, E.M. Galati, Farmaco 50 (1995) 595–599.
- 8.E. Tripoli, M. Guardia, S. Giammanco, D. Majo, M. Giammanco, Food Chem. 104 (2007) 466–479.
- 9.D. Bergqvist, T. Hallbrook, B. Lindblad, A. Lindhagen, Vasa 10 (1981) 253–260.
- 10.P. Damon, O. Flandre, F. Michel, L. Perdrix, C. Labrid, A. Crastes de Paulet, Arzneimittelforschung 37 (1987) 1149–1153.
- 11.J.A. Da Silva Emim, A.B. Oliveira, A.J. Lapa, J. Pharm. Pharmacol. 46 (1994) 118–122.
- 12.M. Gabor, in: V. Cody, E. Middleton Jr, J.B. Harborne, A. Beretz (eds) Plant Flavonoids in Biology and Medicine II: Biochemical, Cellular and Medicinal Properties, Alan R Liss, Inc., New York, 1988, pp. 1–15.
- 13.J.A. Del Rioa, M.D. Fustera, P. Gomeza, I. Porrasb, A. Garcia- Lidonb, A. Ortunoa, Food Chem. 84 (2004) 457–461.
- 14.F.A. El-Yazbi, M. El-Swify, Y. Hawam, Bull. Fac. Pharm. Cairo Univ. 37 (1999) 19–24.
- 15.C.W. Chang, S.L. Hsiu, P.P. Wu, S.C. Kuo, P.D.L. Chao, J. Food Drug Anal. 5 (1997) 111–120.
- [16]
A. Marston, K. Hostettmann, in: (eds) Flavonoids: Chemistry, Biochemistry and Applications, CRC Press, Taylor & Francis Group, Boca Raton, 2006, p. 1–36.
- 17.D. Cova, L. De Angelis, F. Giavarini, G. Palladini, R. Perego, Int. J. Clin. Pharm. Therap. Toxicol. 30 (1992) 29–33.
- 18.A. El Bayoumi, Anal. Lett. 32 (1999) 383–400.
- 19.A.D. Kaur, V. Ravichandran, P.K. Jain, R.K. Agrawal, J. Pharm. Biomed. Anal. 46 (2008) 391–394.
- 20.S.A. Coran, G. Bartolucci, M. Bambagiotti-Alberti, J. Pharm. Biomed. Anal. 54 (2011) 422–425.
- 21.K. Shanker, S. Gupta, P. Srivastava, S.K. Srivastava, S.C. Singh, M.M. Gupta, J. Pharm. Biomed. Anal. 54 (2011) 497–502.
- 22.V. Srivastava, M. Singh, R. Malasoni, K. Shanker, R.K. Verma, M.M. Gupta, A.K. Gupta, S.P.S. Khanuja, J. Sep. Sci. 31 (2008) 47–55.
- 23.A.K. Yadav, N. Tiwari, P. Srivastava, S.C. Singh, K. Shanker, R.K. Verma, J. Pharm. Biomed. Anal. 47 (2008) 841–846.
- 24.F.I. Kanaze, C. Gabrieli, E. Kokkalou, M. Georgarakis, I. Niopas, J. Pharm. Biomed. Anal. 33 (2003) 243–249.
- 25.ICH, Text on Validation of Analytical Procedures — ICH Harmonised Tripartite Guideline, Geneva, 1994.
- 26.ICH, Validation of Analytical Procedures: Methodology — ICH Harmonised Tripartite Guideline, Geneva, 1996.
- 27.M.R. Lauro, M.L. Torre, L. Maggi, F. De Simone, U. Conte, R.P. Aquino, Pharm. Sci. 11 (2001) 265–269.